Bakker, Bert: transcript of a video interview (27-Oct-2015)
Series
History of Modern Biomedicine Interviews (Digital Collection);e2017075
History of Modern Biomedicine Interviews (Digital Collection);e2017076
History of Modern Biomedicine Interviews (Digital Collection);e2017077
History of Modern Biomedicine Interviews (Digital Collection);e2017078
History of Modern Biomedicine Interviews (Digital Collection);e2017079
History of Modern Biomedicine Interviews (Digital Collection);e2017080
History of Modern Biomedicine Interviews (Digital Collection);e2017081
History of Modern Biomedicine Interviews (Digital Collection);e2017082
DOI
10.17636/01020340
Metadata
Show full item recordAbstract
Interview with Professor Bert Bakker, conducted by Ms Emma M. Jones, for the History of Modern Biomedicine Research Group, 27 October 2015, in the School of History, Queen Mary University of London. Transcribed by Mrs Debra Gee, and edited by Professor Tilli Tansey and Ms Emma M. Jones. The project management and the technical support (filming and production) were undertaken by Mr Adam Wilkinson and Mr Alan Yabsley, respectively. Professor Egbert (Bert) Bakker PhD (b. 1951) studied chemistry in Delft (BSc), and continued his studies at Leiden University (1975-1976) where he was also a technician (1977-1989). During this period he worked closely with Professor Peter L Pearson and pioneered molecular genetic techniques, which led to the first prenatal diagnosis of Duchenne muscular dystrophy in 1985. In 1989 he completed his doctoral research on Duchenne muscular dystrophy, and the same year he was awarded the Lustrum Prize by the Dutch Human Genetics Society. In 1990 he became Head of the DNA diagnostic section in Leiden University’s Clinical Genetic Centre and Associate Professor at the Department of Human Genetics. In conjunction with these roles, he was Head of the Forensic DNA Laboratory at Leiden (1994-2000). In 2000 he was appointed Professor of Molecular Genetic Diagnosis at Leiden University Medical Center, where he continued as Head of the Laboratory for Diagnostic Genome Analysis, till April 2015, when he stepped down as Head of the laboratory and ceased his management duties.
Authors
Jones EM
Bakker B
Tansey EM
Jones EM
Gee D
Yabsley A
Wilkinson A